Upload Avatar (500 x 500)
Xiaofeng Zheng
{'en': 'xiaofengz (AT) pku.edu.cn', 'zh': 'xiaofengz (AT) pku.edu.cn', 'de': 'xiaofengz (AT) pku.edu.cn'}
Chinese, English
Beijing
Peking University
Life Sciences
  • Ph.D. in Biochemistry and Molecular Biology, Tokyo University of Agriculture and Technology
  • Postdoctoral Research Fellow, Pennsylvania State University
  • Vice Director of the National Key Laboratory of Protein and Gene Research
  • 2008 June - Present, Professor, Peking University, School of Life Sciences
  • 2002 May - 2008 May, Associate Professor, Peking University, School of Life Sciences
  • 1998 April - 2002 April, Postdoctoral Research Fellow, University of Pennsylvania
  • Bayer Scholar Award, 2020
  • Outstanding Doctoral Dissertation Advisor, Peking University, 2020
  • Outstanding Teaching Award, Peking University, 2017
  • Outstanding Class Advisor, Peking University, 2016
  • Outstanding Doctoral Dissertation Advisor, Peking University, 2016
  • Outstanding Doctoral Dissertation Advisor, Peking University, 2014
  • Dongbao Teacher Award, Peking University, 2013
  • Dongbao Teacher Award, Peking University, 2009
  • Outstanding Young Teacher Basic Skills Award, Peking University, 2007
  • Dongbao Teacher Award, Peking University, 2006
  • Outstanding Counselor, Beijing, 2006
  • Tan Jiazhen Fund Life Science Mentor Award, 2006
  • Outstanding Class Advisor, Peking University, 2005
Identification and molecular mechanisms of proteins regulating tumor development and metastasis
DNA damage repair—Genomic stability—Cancer
Virus—Innate immunity—DNA damage response—Inflammation and cancer
  • ATM-ESCO2-SMC3 axis promotes 53BP1 recruitment in response to DNA damage and safeguards genome integrity by stabilizing cohesin complex, Fu JF, Zhou SR, Xu HL, Liao LM, Shen H, Du P, Zheng XF, 2023
  • Metabolic Interventions Combined with CTLA-4 and PD-1/PD-L1 Blockade for the Treatment of Tumors: Mechanisms and Strategies, Liao LM, Xu HL, Zhao YH, Zheng XF, 2023
  • SENP1 decreases RNF168 phase separation to promote DNA damage repair and drug resistance in colon cancer, Wei M, Huang XP, Liao LM, Tian YL, Zheng XF, 2023
  • hCINAP alleviates senescence through regulating MDM2 status via multiple mechanisms, Huang XP, Zhao Y, Wei M, Zhuge RP, Zheng XF, 2023
  • hCINAP controls lineage differentiation of embryonic stem cells by regulating NEDD4 liquid-liquid phase separation-mediated YAP1 activation, Zhuge RP, Wang C, Wang J, Yu SY, Liao LM, Zheng XF, 2023
  • PRMT5-mediated RNF4 methylation promotes therapeutic resistance of APL cells to As2O3 by stabilizing oncoprotein PML-RARα, Huang XP, Yang YF, Zhu D, Zhao Y, Wei M, Li K, Zu HH, Zheng XF, 2022
  • Deubiquitinase OTUD6A promotes breast cancer progression by increasing TopBP1 stability and rendering tumor cells resistant to DNA-damaging therapy, Zhao Y, Huang XP, Zhu D, Wei M, Yu SY, Tian YL, Zheng XF, 2022
  • Deubiquitinase OTUB2 exacerbates the progression of colorectal cancer by promoting PKM2 activity and glycolysis, Yu SY, Zang WC, Oiu YC, Liao LM, Zheng XF, 2022
  • Unique structural features of the adenylate kinase hCINAP/AK6 and its multifaceted functions in carcinogenesis and tumor progression, Xu RD, Yang YF, Zheng XF, 2021
  • Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1, Zhu D, Xu R, Huang X, Tang Z, Tian Y, Zhang J, Zheng XF, 2021
Tumor Metastasis Proteins Molecular Mechanisms Dna Damage Repair Genomic Stability Virus Innate Immunity Inflammation

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.